Theme 3: Implementation Trials
Co-Investigators:
Prof Jenny Hill, Professor Eve Worrall, Amanda McCoy and Jenna Hoyt (LSTM)
Dr Manfred Accrombessi (IRCB) and Dr Juliet Otieno (KEMRI)
Implementation research is central to PDMC Saves Lives, helping to bridge the gap between evidence and the practical delivery of post-discharge malaria chemoprevention (PDMC) within routine health systems. The implementation studies in Benin and Kenya were designed with national stakeholders to explore how PDMC can be delivered in ways that are practical, acceptable and sustainable, including different approaches to medicine delivery and support for caregivers. This work is complemented by acceptability and feasibility research, which considers the experiences and perspectives of caregivers, healthcare providers and other stakeholders, and health-economic research examining the resources and costs associated with different delivery approaches. Together, these activities will provide the evidence needed to inform decisions about how PDMC could be integrated into health systems and delivered sustainably at scale.
In Benin, the implementation trial builds on this approach by exploring how PDMC can be delivered through existing health facilities and community systems, including approaches involving community health workers and support for caregivers. Recruitment has been completed and participant follow-up is reaching completion, alongside ongoing data cleaning and validation. The next phase will bring together the different strands of the study, completing trial close-out and the planned statistical, health-economic and acceptability and feasibility analyses. This will be followed by engagement with national and regional stakeholders to consider how the evidence can inform future approaches to PDMC delivery and implementation in Benin.
In Kenya, the implementation trial similarly examines how PDMC can be incorporated into routine care following a child’s discharge from hospital, testing different approaches to medicine delivery and caregiver support within the health system. Participant follow-up and close-out monitoring have now been completed, and the study is progressing through final data-quality checks, database preparation and analysis planning. The next phase will complete the planned trial, health-economic, process, and acceptability and feasibility analyses, bringing these different sources of evidence together to build a fuller picture of what is required for routine delivery. Engagement with county, national and regional stakeholders will then support consideration of the evidence and its implications for future PDMC policy and implementation.







